載入...
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
Abstract Background Use of rituximab (RTX) for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is widely described in children. Clinical evidence in adults is limited. The objective of this study was to determine the treatment outcomes of RTX in adults with FSGS and MCD. M...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2020-04-01
|
| 叢編: | BMC Nephrology |
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s12882-020-01797-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|